409 related articles for article (PubMed ID: 19445547)
21. Drugs, bugs, and esophageal pH profiles.
Robinson M
Yale J Biol Med; 1999; 72(2-3):169-72. PubMed ID: 10780578
[TBL] [Abstract][Full Text] [Related]
22. Results of short-and long-term medical treatment of gastroesophageal reflux disease (GERD).
Pohle T; Domschke W
Langenbecks Arch Surg; 2000 Aug; 385(5):317-23. PubMed ID: 11026702
[TBL] [Abstract][Full Text] [Related]
23. Medical treatment of gastro-oesophageal reflux disease.
De Giorgi F; Savarese MF; Atteo E; Leone CA; Cuomo R
Acta Otorhinolaryngol Ital; 2006 Oct; 26(5):276-80. PubMed ID: 17345932
[TBL] [Abstract][Full Text] [Related]
24. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
van Pinxteren B; Sigterman KE; Bonis P; Lau J; Numans ME
Cochrane Database Syst Rev; 2010 Nov; (11):CD002095. PubMed ID: 21069670
[TBL] [Abstract][Full Text] [Related]
25. Treatment of PPI-resistant gastro-oesophageal reflux: A systematic review.
Gallusi G; Pontone S
Arab J Gastroenterol; 2018 Jun; 19(2):51-55. PubMed ID: 29935866
[TBL] [Abstract][Full Text] [Related]
26. Alginate therapy is effective treatment for gastroesophageal reflux disease symptoms: a systematic review and meta-analysis.
Leiman DA; Riff BP; Morgan S; Metz DC; Falk GW; French B; Umscheid CA; Lewis JD
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 27671545
[TBL] [Abstract][Full Text] [Related]
27. Alginate therapy is effective treatment for GERD symptoms: a systematic review and meta-analysis.
Leiman DA; Riff BP; Morgan S; Metz DC; Falk GW; French B; Umscheid CA; Lewis JD
Dis Esophagus; 2017 May; 30(5):1-9. PubMed ID: 28375448
[TBL] [Abstract][Full Text] [Related]
28. Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease.
Richter JE; Campbell DR; Kahrilas PJ; Huang B; Fludas C
Arch Intern Med; 2000 Jun; 160(12):1803-9. PubMed ID: 10871974
[TBL] [Abstract][Full Text] [Related]
29. HISTORICAL PERSPECTIVE OF GASTROESOPHAGEAL REFLUX DISEASE CLINICAL TREATMENT.
Zaterka S; Marion SB; Roveda F; Perrotti MA; Chinzon D
Arq Gastroenterol; 2019 Aug; 56(2):202-208. PubMed ID: 31460587
[TBL] [Abstract][Full Text] [Related]
30. Metoclopramide, thickened feedings, and positioning for gastro-oesophageal reflux in children under two years.
Craig WR; Hanlon-Dearman A; Sinclair C; Taback S; Moffatt M
Cochrane Database Syst Rev; 2004 Oct; (4):CD003502. PubMed ID: 15495056
[TBL] [Abstract][Full Text] [Related]
31. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
van Pinxteren B; Numans ME; Bonis PA; Lau J
Cochrane Database Syst Rev; 2006 Jul; (3):CD002095. PubMed ID: 16855986
[TBL] [Abstract][Full Text] [Related]
32. Management of gastroesophageal reflux disease: medications, surgery, or endoscopic therapy? (Current status and trends).
Zhi XT; Kavic SM; Park AE
J Long Term Eff Med Implants; 2005; 15(4):375-88. PubMed ID: 16022648
[TBL] [Abstract][Full Text] [Related]
33. Overlapping approach Proton Pump Inhibitors/Nux vomica-Heel as new intervention for gastro-esophageal reflux management: Delphi consensus study.
Battaglia E; Bertolusso L; Del Prete M; Monzani M; Astegiano M
World J Gastroenterol; 2024 May; 30(18):2467-2478. PubMed ID: 38764766
[TBL] [Abstract][Full Text] [Related]
34. WITHDRAWN: Metoclopramide, thickened feedings, and positioning for gastro-oesophageal reflux in children under two years.
Craig WR; Hanlon-Dearman A; Sinclair C; Taback SP; Moffatt M
Cochrane Database Syst Rev; 2010 May; 2010(5):CD003502. PubMed ID: 20464724
[TBL] [Abstract][Full Text] [Related]
35. Heartburn, gastroesophageal reflux (GER), and gastroesophageal reflux disease (GERD).
J Pract Nurs; 2008; 58(3):21-3. PubMed ID: 19180847
[No Abstract] [Full Text] [Related]
36. Combination drug therapy for gastroesophageal reflux disease.
Cross LB; Justice LN
Ann Pharmacother; 2002 May; 36(5):912-6. PubMed ID: 11978171
[TBL] [Abstract][Full Text] [Related]
37. Medical treatment of gastroesophageal reflux disease: options and priorities.
Thomson AB
Hepatogastroenterology; 1992 Feb; 39 Suppl 1():14-23. PubMed ID: 1349550
[TBL] [Abstract][Full Text] [Related]
38. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
van Pinxteren B; Numans ME; Bonis PA; Lau J
Cochrane Database Syst Rev; 2004 Oct; (4):CD002095. PubMed ID: 15495027
[TBL] [Abstract][Full Text] [Related]
39. Review: treatment of gastroesophageal reflux disease in the elderly.
Poh CH; Navarro-Rodriguez T; Fass R
Am J Med; 2010 Jun; 123(6):496-501. PubMed ID: 20569750
[TBL] [Abstract][Full Text] [Related]
40. New algorithm for the treatment of gastro-oesophageal reflux disease.
Tytgat GN; McColl K; Tack J; Holtmann G; Hunt RH; Malfertheiner P; Hungin AP; Batchelor HK
Aliment Pharmacol Ther; 2008 Feb; 27(3):249-56. PubMed ID: 17973975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
